ERBB2 and breast carcinoma: Despite ERBB2 being a well-known oncogene and regarded as a crucial diagnostic/prognostic biomarker and therapeutic target in multiple tumors, such as breast cancer (Wynn and Tang, 2022), the exact function of ERBB2 in tumors remains largely unknown.